GlassScriptPhysician profile
Paul Ray Clark
NPI 1619362597
$5,104.09
in general payments reported to CMS, 2019-2025
13 companies · $835 in 2025
The $835 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $476 · 2023: $2,646 · 2024: $1,147 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319 · Travel and Lodging: $1,363 · Long Term Medical Supply Or Device Loan: $652 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,319.10 |
| Travel and Lodging | $1,363.24 |
| Long Term Medical Supply Or Device Loan | $651.60 |
| Education | $293.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,685.29 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Integra Lifesciences Corporation | $813.07 | 2022-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Allergan, INC. | $442.46 | 2022 | |
| Kls-Martin L.P. | $305.88 | 2024 | |
| Medical Device Business Services, INC. | $293.99 | 2024 | |
| Galderma Laboratories, L.P. | $185.11 | 2023-2025 | Dysport |
| Medtronic, INC. | $155.69 | 2024 | V-Loc 180 |
| Tela Bio, INC. | $100.00 | 2024 | Ovitex 2s |
| Avita Medical Americas, LLC | $39.81 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $30.16 | 2024 | Exparel |
| Solta Medical, A Division of Bausch Health US, LLC | $21.71 | 2024 | |
| Vertical Pharmaceuticals, LLC | $16.91 | 2024 | Dsuvia |
| Polynovo North America LLC | $14.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.